- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/00 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
Patent holdings for IPC class C07D 271/00
Total number of patents in this class: 19
10-year publication summary
|
0
|
0
|
2
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3748 |
2 |
| Bristol-myers Squibb Company | 4861 |
1 |
| F. Hoffmann-La Roche AG | 7951 |
1 |
| Boehringer Ingelheim International GmbH | 4750 |
1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 93 |
1 |
| Bayer Cropscience AG | 2136 |
1 |
| Amgen Inc. | 3904 |
1 |
| Merck Sharp & Dohme B.V. | 562 |
1 |
| Mayo Foundation for Medical Education and Research | 3126 |
1 |
| Northwestern University | 3290 |
1 |
| Chen, Chung-chin | 40 |
1 |
| RespireRx Pharmaceuticals Inc | 10 |
1 |
| Third-Order Nanotechnologies, Inc. | 1 |
1 |
| U.S. Army Medical Research and Materiel Command | 11 |
1 |
| Washington University | 1548 |
1 |
| SpecGx LLC | 196 |
1 |
| Alphala Co., Ltd. | 18 |
1 |
| Celltaxis, LLC | 28 |
1 |
| Other owners | 0 |